日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival

4-基于大型临床癌症登记队列的乳腺癌亚型免疫组化分类：在临床常规治疗决策中的应用及其对生存率的影响

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-015-3572-3
Inwald, Elisabeth Christine; Koller, M; Klinkhammer-Schalke, M; Zeman, F; Hofstädter, F; Gerstenhauer, M; Brockhoff, G; Ortmann, O
肿瘤
IHC
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2015
文献求助 收藏

Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry

辅助内分泌治疗在绝经前与绝经后类固醇激素受体阳性乳腺癌患者中的应用：一项基于癌症登记处大型人群队列的研究结果。

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-015-2025-z
Inwald, E C; Koller, M; Klinkhammer-Schalke, M; Zeman, F; Hofstädter, F; Lindberg, P; Gerstenhauer, M; Schüler, S; Treeck, O; Ortmann, O
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2015
文献求助 收藏

Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry

指南推荐疗法可延长HER2阳性乳腺癌患者的生存期：一项基于癌症登记处大型人群队列的研究结果。

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2014/137304
Inwald, E C; Ortmann, O; Zeman, F; Koller, M; Hofstädter, F; Gerstenhauer, M; Klinkhammer-Schalke, M
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2014
文献求助 收藏

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

Ki-67是乳腺癌患者的预后指标：一项基于癌症登记处大型人群队列研究的结果。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-013-2560-8
Inwald, E C; Klinkhammer-Schalke, M; Hofstädter, F; Zeman, F; Koller, M; Gerstenhauer, M; Ortmann, O
Ki-67
肿瘤
肿瘤免疫
乳腺癌
发表日期：2013
文献求助 收藏